✦ LIBER ✦

Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan

✍ Scribed by Wenyu Ye; Shinji Fujikoshi; Naohiro Nakahara; Michihiro Takahashi; Haya Ascher-Svanum; Tetsuro Ohmori

Book ID: 115173864
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 391 KB
Volume: 66
Category: Article
ISSN: 1323-1316
DOI: 10.1111/j.1440-1819.2012.02351.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH8 IMPROVED TREATMENT OUTCOMES FOLLOWI

PMH8 IMPROVED TREATMENT OUTCOMES FOLLOWING A SWITCH FROM RISPERIDONE TO OLANZAPINE IN A 1-YEAR NATURALISTIC STUDY OF SCHIZOPHRENIA PATIENTS IN JAPAN

✍ W Ye; S Fujikoshi; N Nakahara; M Takahashi; H Ascher-Svanum 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Belgian Schizophrenia Outcome Survey – R

Belgian Schizophrenia Outcome Survey – Results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol

✍ J. Peuskens; B. Gillain; D. De Graeve; B. Van Vleymen; A. Albert 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 320 KB

Risperidone, olanzapine and quetiapine i

Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: Preliminary findings from a naturalistic, retrospective study

✍ PAOLA ROCCA; FEDERICA MARINO; CRISTIANA MONTEMAGNI; DAVIDE PERRONE; FILIPPO BOGE 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

How effective is it to sequentially swit

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?—A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting

✍ Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Kensuke Nomura; Hiroyoshi T 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 199 KB

P.3.104 Long-term outcome of switching f

P.3.104 Long-term outcome of switching from clozapine to zotepine in refractory schizophrenia: a 2-year follow-up study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Could HTR2A T102C and DRD3 Ser9Gly predi

Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting

✍ Byungsu Kim; Eui Yul Choi; Chang Yoon Kim; Kyuyung Song; Yeon Ho Joo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract ## Objective This study seeks to replicate previous results indicating that T102C in the serotonin 2A receptor (HTR2A) and Ser9Gly in the dopamine D3 receptor (DRD3) were associated with a risperidone response to acutely exacerbated schizophrenia, and to determine whether possession of